Amneal Pharmaceuticals Inc. AMRX
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Amneal Pharmaceuticals Inc. is a global biopharmaceutical company that develops, manufactures, and distributes a diverse portfolio of essential medicines across three reportable segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers a broad range of generic pharmaceuticals in var…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees8,700
TickerAMRX
Statistics
Market Cap$5.18B
Revenue (TTM)$3.02B
Net Income$72.1M
Net Margin2.4%
EPS$0.22
P/E44.16
P/S1.71
P/B-112.16
EV/EBITDA11.18
ROE-101.0%
Dividend Yield—
Price$16.25
Data: Twelve Data · Revenue = mcap / P/S